Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Aims to identify new opportunities for drug discovery through the use of antibodies
November 8, 2016
By: Kristin Brooks
Managing Editor, Contract Pharma
MRC Technology, UCB and the University of Leicester have formed a new research consortium aimed at identifying new opportunities for drug discovery through the use of antibodies in structure-based drug discovery and design. The consortium will use antibodies to identify and characterize novel regulatory or allosteric sites on therapeutic target proteins, to stabilize functionally of important protein conformational states, and to characterize key structural features of complexes formed with activity modulating antibodies. The knowledge gained using this approach will be used to guide the discovery and design of novel small molecule therapeutics. Justin Bryans, director, Drug Discovery at MRC Technology, said, “As a charity, it is part of MRC Technology’s strategy to pursue riskier technologies if it can expedite new treatments to patients. Our capabilities in both antibody and small molecule drug discovery leave us ideally placed to help drive this new technology towards the clinic. Collaborating with UCB and the University of Leicester will undoubtedly help us achieve our ambition in this field.” Alistair Henry, Senior Director of Biological Spectroscopy at UCB, said, “UCB sees partnerships as fundamental to our success as the complexities of treating severe diseases are beyond the expertise and resource of a single organisation. Collaborating with MRC Technology and the University of Leicester to combine our expertise to open up new treatment opportunities through Antibody-Assisted Structure-Based Drug Discovery is a very exciting new venture.” The Antibody-Assisted Structure-Based Drug Discovery consortium is recruiting four research scientists to be based at the Leicester Institute of Structural and Chemical Biology. The consortium’s projects will be supported by scientists at MRC Technology and UCB’s research laboratories and will have access to their antibody production facilities.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !